Oyogoa E, Sonpatki M, Brinkerhoff B, Andeen N, Meyer H, Ryan C
Curr Oncol. 2024; 31(5):2393-2399.
PMID: 38785459
PMC: 11119923.
DOI: 10.3390/curroncol31050178.
Li P, Haines G, Si Q, Baskovich B
Int J Clin Exp Pathol. 2024; 17(3):78-82.
PMID: 38577694
PMC: 10988092.
DOI: 10.62347/ZQCI9925.
Alasker A, Shafqat A, Sabbah B, Alghafees M, Al Saud A, Aljabi N
Ann Med Surg (Lond). 2023; 85(12):5869-5873.
PMID: 38098589
PMC: 10718388.
DOI: 10.1097/MS9.0000000000001220.
Autio K, McBride S
J Immunother Precis Oncol. 2022; 5(3):79-83.
PMID: 36034583
PMC: 9390704.
DOI: 10.36401/JIPO-22-4.
Hutten R, Weil C, Tward J, Lloyd S, Johnson S
Eur Urol Open Sci. 2021; 23:30-33.
PMID: 34337486
PMC: 8317810.
DOI: 10.1016/j.euros.2020.11.008.
Challenge and Outcome for the Prostate Squamous Cell Carcinoma Which Developed 8 Years after Low-Dose-Rate Brachytherapy Approached by a Combined Multimodal Treatment with High-Dose-Rate Interstitial Brachytherapy, External Beam Radiation Therapy,....
Matsugasumi T, Masui K, Yamada K, Watanabe S, Okihara K, Kozawa N
Case Rep Oncol. 2021; 14(2):854-860.
PMID: 34248551
PMC: 8255723.
DOI: 10.1159/000516034.
Histological and immunohistochemical investigation of canine prostate carcinoma with identification of common intraductal carcinoma component.
de Brot S, Lothion-Roy J, Grau-Roma L, White E, Guscetti F, Rubin M
Vet Comp Oncol. 2021; 20(1):38-49.
PMID: 33963663
PMC: 9292867.
DOI: 10.1111/vco.12704.
Transformation of a prostatic adenocarcinoma into squamous cell carcinoma after luteinizing hormone-releasing hormone (LHRH) agonist and radiotherapy treatment.
Ichaoui H, Ben Nasr S, Gargouri F, Zribi A, Hermi A, Fendri S
Pan Afr Med J. 2021; 34:125.
PMID: 33708294
PMC: 7906544.
DOI: 10.11604/pamj.2019.34.125.19421.
Prostate squamous cell carcinoma developing 11 years after external radiotherapy for prostate adenocarcinoma.
Matsugasumi T, Nakanishi H, Yokota T, Shiraishi T, Ukimura O
IJU Case Rep. 2021; 3(4):121-124.
PMID: 33392467
PMC: 7770592.
DOI: 10.1002/iju5.12161.
Primary prostatic squamous cell carcinoma.
Hanna K, Lele S, McCormick G, McMahon A, Hill B, Boyle S
Urol Case Rep. 2020; 34:101478.
PMID: 33235827
PMC: 7670195.
DOI: 10.1016/j.eucr.2020.101478.
Competence against insufficiency: Why are men mostly safe from a rare and deadly prostate cancer?.
Mathew G, Trotman L
J Exp Med. 2020; 217(6).
PMID: 32236496
PMC: 7971130.
DOI: 10.1084/jem.20200087.
Post-Brachytherapy Transformation of Prostatic Adenocarcinoma to Squamous Cell Carcinoma: A Cadaver Anatomy Case Report.
DAngelo J, Bhaskar N, Friedes C, Husain M
Cureus. 2020; 11(11):e6184.
PMID: 31890390
PMC: 6913902.
DOI: 10.7759/cureus.6184.
Transformation of adenocarcinoma of prostate to squamous cell carcinoma following hormonal treatment: A case report and review of the literature.
Lee J
Radiol Case Rep. 2019; 14(4):483-489.
PMID: 30805072
PMC: 6374616.
DOI: 10.1016/j.radcr.2019.01.015.
Primary squamous cell carcinoma of the prostate: a case report of a rare clinical entity.
Biswas T, Podder T, Lepera P, Walker P
Future Sci OA. 2016; 1(3):FSO18.
PMID: 28031893
PMC: 5138001.
DOI: 10.4155/fso.15.16.
Primary Adenocarcinoma of the Urethra: A Case Report and Review of the Literature.
Basiri A, Narouie B, Moghadasi M, Ghasemi-Rad M, Valipour R
J Endourol Case Rep. 2016; 1(1):75-7.
PMID: 27579397
PMC: 4996557.
DOI: 10.1089/cren.2015.0026.
Squamous cell carcinoma of the prostate following treatment with an LHRH-agonist: a rare case of transformation of adenocarcinoma of the prostate.
Al-Qassim Z, Mohammed A, Payne D, Stocks P, Khan Z
Cent European J Urol. 2014; 67(1):26-8.
PMID: 24982776
PMC: 4074708.
DOI: 10.5173/ceju.2014.01.art5.
An extraordinary T/NK lymphoma, nasal type, occurring primarily in the prostate gland with unusual CD30 positivity: case report and review of the literature.
Jiang Q, Liu S, Peng J, Xiong H, Xiong Z, Yang Y
Diagn Pathol. 2013; 8:94.
PMID: 23773344
PMC: 3707818.
DOI: 10.1186/1746-1596-8-94.
Prostatic stromal sarcoma with neuroectodermal differentiation.
Yamazaki H, Ohyama T, Tsuboi T, Taoka Y, Kohguchi D, Iguchi H
Diagn Pathol. 2012; 7:173.
PMID: 23217062
PMC: 3542249.
DOI: 10.1186/1746-1596-7-173.